<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Pfizer Sanctioned By Court For Delays And Abuses</title>
	<atom:link href="http://www.pharmalot.com/2009/10/pfizer-sanctioned-by-court-for-delays-and-abuses/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2009/10/pfizer-sanctioned-by-court-for-delays-and-abuses/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Wed, 17 Mar 2010 01:58:03 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Christopher</title>
		<link>http://www.pharmalot.com/2009/10/pfizer-sanctioned-by-court-for-delays-and-abuses/#comment-442306</link>
		<dc:creator>Christopher</dc:creator>
		<pubDate>Wed, 28 Oct 2009 21:28:42 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=19400#comment-442306</guid>
		<description>The award made to BYU is minimal and doesn't seem to correspond with the Magistrate's reprimand. I believe what matters is the nature of the deal between BYU and Monsanto. If it involved payment of a fee for access to Simmons' work with no royalty assumed if it resulted in a commercialized product, then the amount of that fee is the subject of discussions. Presumably Pfizer felt that a fee having already been paid, they could move on with his research in a different direction. Hard to know without details, but either way Pfizer can afford $852k. Not all university tech transfer groups are as sharp as the best ones. I don't know about BYU's.</description>
		<content:encoded><![CDATA[<p>The award made to BYU is minimal and doesn&#8217;t seem to correspond with the Magistrate&#8217;s reprimand. I believe what matters is the nature of the deal between BYU and Monsanto. If it involved payment of a fee for access to Simmons&#8217; work with no royalty assumed if it resulted in a commercialized product, then the amount of that fee is the subject of discussions. Presumably Pfizer felt that a fee having already been paid, they could move on with his research in a different direction. Hard to know without details, but either way Pfizer can afford $852k. Not all university tech transfer groups are as sharp as the best ones. I don&#8217;t know about BYU&#8217;s.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
